A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
ConditionHodgkin Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTakeda
About this trial
The main aim is to check how effective BV is for treating adults with HL.
Study medication will be prescribed according to the clinic's standard practice.
Participants will visit the study clinic 5 times, once every 12 weeks. When study treatment has completed, a follow-up visit will be scheduled every 3 months during the first year and every 4-6 months during the next year.
Eligibility criteria
Qualifiers
None
Disqualifiers
Currently participates or plans to participate in any interventional clinical trial.
Any other reason that, in the Investigator's opinion, makes the participant unsuitable to participate in this study.
Trial design
Treatments tested in this trial
- No Intervention
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
13Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu50-556, WroclawDolnoslskie, Poland
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu61-848, PoznanGreater Poland Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Krakowie31-115, KrakowLesser Poland Voivodeship, Poland
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie31-501, KrakowLesser Poland Voivodeship, Poland
Sponsors and collaborators
Takeda
Lead sponsor
Source ClinicalTrials.gov